Risk factors

Medicus Pharma (MDCX) risk factors

Item 1A of every Medicus Pharma Ltd. 10-K on file, and what changed from one year to the next.

Open MDCX in Gloomberb →
  • FY2025 10-K risk factors

    76 risks. Going concern doubt hangs over operations due to ongoing operating losses and a limited operating history. Reliance on the University of Pittsburgh license is absolute for the core SkinJect asset. Integration of recently acquired Antev and its Teverelix asset presents execution risk.

    Filed Mar 25, 2026